Aptevo Therapeutics Inc. (25) | Business Finance (14)

Browse by Subcategory

Recent Contracts

Agreement to Terminate Registration Rights Agreement between the Company and Intervac L.L.C. and BioVac L.L.C (Filed With SEC on March 24, 2022)
Purchase Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
Description of Capital Stock of Aptevo Therapeutics (Filed With SEC on March 31, 2021)
Equity Distribution Agreement, dated December 14, 2020, between Aptevo Therapeutics Inc. and Piper Sandler & Co (Filed With SEC on December 14, 2020)
Amendment No. 1 to Amended and Restated Credit and Security Agreement, dated December 14, 2018, by and among, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC, Aptevo Research... (Filed With SEC on March 18, 2019)
Intellectual Property Security Agreement, dated February 7, 2019, by and amoung, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC., Aptevo Research and Development, LLC and... (Filed With SEC on March 18, 2019)
Underwriting Agreement between Aptevo Therapeutics, Inc. and Piper Jaffray & Co., dated March 7, 2019 (Filed With SEC on March 11, 2019)
Form of Warrant (Filed With SEC on March 11, 2019)
Registration Rights Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
Royalty Purchase Agreement by and among Aptevo Therapeutics Inc. and Healthcare Royalty Partners IV, LP. dated as of March 30, 2021 (Filed With SEC on May 11, 2021)
Rights Agreement, dated as of November 8, 2020, by and between Aptevo Therapeutics Inc. and Broadridge Corporate Issuer Solutions, Inc., as rights agent (Filed With SEC on November 9, 2020)
LLC Purchase Agreement by and among Aptevo Therapeutics Inc. and Medexus Pharma, Inc. dated February 28, 2020 (Filed With SEC on March 2, 2020)
Amendment to LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol... (Filed With SEC on August 9, 2019)
Form of Pre-Funded Warrant (Filed With SEC on March 11, 2019)